{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:56:30Z","timestamp":1794099390055,"version":"4.8.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007356","name":"Adessium Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51676-0","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:03:48Z","timestamp":1724929428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["ATAXIN-2 intermediate-length polyglutamine expansions elicit ALS-associated metabolic and immune phenotypes"],"prefix":"10.1038","volume":"15","author":[{"given":"Renata","family":"Vieira de S\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Sudria-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ca\u00f1izares Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6496-881X","authenticated-orcid":false,"given":"Oliver","family":"Harschnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne M. A.","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Kling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk-Jan","family":"Westeneng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"Karst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Bloemenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy","family":"Varderidou-Minasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6194-4695","authenticated-orcid":false,"given":"Domino K.","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Mars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Broekhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky C. H.","family":"van Kronenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youri","family":"Adolfs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamshidhar R.","family":"Vangoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5530-3954","authenticated-orcid":false,"given":"Rianne","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tijana","family":"Ljubikj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianne","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9348-4750","authenticated-orcid":false,"given":"Sabine","family":"Seeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enric","family":"Mocholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6864-3403","authenticated-orcid":false,"given":"Onur","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giel","family":"Korsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Calafat Pla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten T.","family":"Ven\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1697","authenticated-orcid":false,"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-5883","authenticated-orcid":false,"given":"Michael A.","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-9657","authenticated-orcid":false,"given":"Jan H.","family":"Veldink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavol","family":"Zelina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1631-6440","authenticated-orcid":false,"given":"R. Jeroen","family":"Pasterkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"51676_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162\u2013172 (2017).","journal-title":"N. Engl. J. Med."},{"key":"51676_CR2","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/S0140-6736(17)31287-4","volume":"390","author":"MA van Es","year":"2017","unstructured":"van Es, M. A. et al. Amyotrophic lateral sclerosis. Lancet 390, 2084\u20132098 (2017).","journal-title":"Lancet"},{"key":"51676_CR3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918\u20131929 (2020).","journal-title":"Eur. J. Neurol."},{"key":"51676_CR4","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"51676_CR5","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1242\/dmm.029058","volume":"10","author":"P Van Damme","year":"2017","unstructured":"Van Damme, P., Robberecht, W. & Van Den Bosch, L. Modelling amyotrophic lateral sclerosis: progress and possibilities. Dis. Model. Mech. 10, 537\u2013549 (2017).","journal-title":"Dis. Model. Mech."},{"key":"51676_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2020.08.022","volume":"108","author":"G Kim","year":"2020","unstructured":"Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R. & Gitler, A. D. ALS genetics: gains, losses, and implications for future therapies. Neuron 108, 822\u2013842 (2020).","journal-title":"Neuron"},{"key":"51676_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/jnnp.2010.224501","volume":"82","author":"S Byrne","year":"2011","unstructured":"Byrne, S. et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 82, 623\u2013627 (2011).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"51676_CR8","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jmedgenet-2013-101795","volume":"50","author":"KP Kenna","year":"2013","unstructured":"Kenna, K. P. et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J. Med. Genet. 50, 776\u2013783 (2013).","journal-title":"J. Med. Genet."},{"key":"51676_CR9","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1212\/WNL.0000000000004109","volume":"89","author":"SB Gibson","year":"2017","unstructured":"Gibson, S. B. et al. The evolving genetic risk for sporadic ALS. Neurology 89, 226\u2013233 (2017).","journal-title":"Neurology"},{"key":"51676_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"Z-Y Zou","year":"2017","unstructured":"Zou, Z.-Y. et al. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 88, 540\u2013549 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"51676_CR11","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen, H. P., Van Broeckhoven, C. & van der Zee, J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 34, 404\u2013423 (2018).","journal-title":"Trends Genet."},{"key":"51676_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nature09320","volume":"466","author":"AC Elden","year":"2010","unstructured":"Elden, A. C. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069\u20131075 (2010).","journal-title":"Nature"},{"key":"51676_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.neuron.2011.09.011","volume":"72","author":"M DeJesus-Hernandez","year":"2011","unstructured":"DeJesus-Hernandez, M. et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245\u2013256 (2011).","journal-title":"Neuron"},{"key":"51676_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuron.2011.09.010","volume":"72","author":"AE Renton","year":"2011","unstructured":"Renton, A. E. et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-Linked ALS-FTD. Neuron 72, 257\u2013268 (2011).","journal-title":"Neuron"},{"key":"51676_CR15","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1093\/hmg\/dds064","volume":"21","author":"HM Blauw","year":"2012","unstructured":"Blauw, H. M. et al. NIPA1 polyalanine repeat expansions are associated with amyotrophic lateral sclerosis. Hum. Mol. Genet. 21, 2497\u20132502 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR16","doi-asserted-by":"publisher","first-page":"fcaa064","DOI":"10.1093\/braincomms\/fcaa064","volume":"2","author":"GHP Tazelaar","year":"2020","unstructured":"Tazelaar, G. H. P. et al. ATXN1 repeat expansions confer risk for amyotrophic lateral sclerosis and contribute to TDP-43 mislocalization. Brain Commun. 2, fcaa064\u2013fcaa064 (2020).","journal-title":"Brain Commun."},{"key":"51676_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1212\/WNL.49.4.1009","volume":"49","author":"D Lorenzetti","year":"1997","unstructured":"Lorenzetti, D., Bohlega, S. & Zoghbi, H. Y. The expansion of the CAG repeat in ataxin-2 is a frequent cause of autosomal dominant spinocerebellar ataxia. Neurology 49, 1009\u20131013 (1997).","journal-title":"Neurology"},{"key":"51676_CR18","doi-asserted-by":"crossref","unstructured":"Scoles, D. R. & Pulst, S. M. Spinocerebellar ataxia type 2 BT - polyglutamine disorders. In: C. N\u00f3brega and L. Pereira de Almeida, eds. (Springer International Publishing), pp. 175\u2013195 (2018).","DOI":"10.1007\/978-3-319-71779-1_8"},{"key":"51676_CR19","doi-asserted-by":"publisher","first-page":"178.e1","DOI":"10.1016\/j.neurobiolaging.2016.11.010","volume":"51","author":"W Sproviero","year":"2017","unstructured":"Sproviero, W. et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol. Aging 51, 178.e1\u2013178.e9 (2017).","journal-title":"Neurobiol. Aging"},{"key":"51676_CR20","doi-asserted-by":"crossref","unstructured":"Laffita-Mesa, J. M., Paucar, M. & Svenningsson, P. Ataxin-2 gene: a powerful modulator of neurological disorders. Curr. Opin. Neurol. 34, 578\u2013588 (2021).","DOI":"10.1097\/WCO.0000000000000959"},{"key":"51676_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/genes8060157","volume":"8","author":"LA Ostrowski","year":"2017","unstructured":"Ostrowski, L. A., Hall, A. C. & Mekhail, K. Ataxin-2: from RNA control to human health and disease. Genes (Basel) 8, 2\u201321 (2017).","journal-title":"Genes (Basel)"},{"key":"51676_CR22","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1093\/hmg\/ddr227","volume":"20","author":"OA Ross","year":"2011","unstructured":"Ross, O. A. et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum. Mol. Genet. 20, 3207\u20133212 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR23","doi-asserted-by":"publisher","first-page":"2906.e1","DOI":"10.1016\/j.neurobiolaging.2015.06.013","volume":"36","author":"G Borghero","year":"2015","unstructured":"Borghero, G. et al. ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry. Neurobiol. Aging 36, 2906.e1\u20132906.e29065 (2015).","journal-title":"Neurobiol. Aging"},{"key":"51676_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1212\/WNL.0000000000001159","volume":"84","author":"A Chi\u00f2","year":"2015","unstructured":"Chi\u00f2, A. et al. ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology 84, 251\u2013258 (2015).","journal-title":"Neurology"},{"key":"51676_CR25","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1212\/WNL.0b013e31821f445b","volume":"76","author":"P Van Damme","year":"2011","unstructured":"Van Damme, P. et al. Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2. Neurology 76, 2066\u20132072 (2011).","journal-title":"Neurology"},{"key":"51676_CR26","doi-asserted-by":"publisher","first-page":"e105534","DOI":"10.1371\/journal.pone.0105534","volume":"9","author":"M-D Wang","year":"2014","unstructured":"Wang, M.-D., Gomes, J., Cashman, N. R., Little, J. & Krewski, D. Intermediate CAG repeat expansion in the ATXN2 gene is a unique genetic risk factor for ALS-a systematic review and meta-analysis of observational studies. PLoS One 9, e105534\u2013e105534 (2014).","journal-title":"PLoS One"},{"key":"51676_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jamaneurol.2014.2082","volume":"71","author":"AG Neuenschwander","year":"2014","unstructured":"Neuenschwander, A. G., Thai, K. K., Figueroa, K. P. & Pulst, S. M. Amyotrophic lateral sclerosis risk for spinocerebellar ataxia type 2 ATXN2 CAG repeat alleles: a meta-analysis. JAMA Neurol. 71, 1529\u20131534 (2014).","journal-title":"JAMA Neurol."},{"key":"51676_CR28","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1093\/brain\/awac167","volume":"145","author":"Glass","year":"2022","unstructured":"Glass et al. ATXN2 intermediate expansions in amyotrophic lateral sclerosis. Brain 145, 2671\u20132676 (2022).","journal-title":"Brain"},{"key":"51676_CR29","doi-asserted-by":"publisher","first-page":"9133","DOI":"10.1523\/JNEUROSCI.0996-12.2012","volume":"32","author":"MP Hart","year":"2012","unstructured":"Hart, M. P. & Gitler, A. D. ALS-associated ataxin 2 PolyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J. Neurosci. 32, 9133\u20139142 (2012).","journal-title":"J. Neurosci."},{"key":"51676_CR30","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00401-016-1575-8","volume":"132","author":"AM Blokhuis","year":"2016","unstructured":"Blokhuis, A. M. et al. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol. 132, 175\u2013196 (2016).","journal-title":"Acta Neuropathol."},{"key":"51676_CR31","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/nature22038","volume":"544","author":"LA Becker","year":"2017","unstructured":"Becker, L. A. et al. Therapeutic reduction of ataxin 2 extends lifespan and reduces pathology in TDP-43 mice. Nature 544, 367 (2017).","journal-title":"Nature"},{"key":"51676_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature22044","volume":"544","author":"DR Scoles","year":"2017","unstructured":"Scoles, D. R. et al. Antisense oligonucleotide therapy for spinocerebellar ataxia type 2. Nature 544, 362\u2013366 (2017).","journal-title":"Nature"},{"key":"51676_CR33","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40478-020-01055-9","volume":"8","author":"R Watanabe","year":"2020","unstructured":"Watanabe, R. et al. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions. Acta Neuropathol. Commun. 8, 176 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"51676_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2005.10.186","volume":"339","author":"T-R Kiehl","year":"2006","unstructured":"Kiehl, T.-R. et al. Generation and characterization of Sca2 (ataxin-2) knockout mice. Biochem. Biophys. Res. Commun. 339, 17\u201324 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"51676_CR35","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/hmg\/ddn035","volume":"17","author":"I Lastres-Becker","year":"2008","unstructured":"Lastres-Becker, I. et al. Insulin receptor and lipid metabolism pathology in ataxin-2 knock-out mice. Hum. Mol. Genet. 17, 1465\u20131481 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR36","doi-asserted-by":"crossref","unstructured":"Damrath, E. et al. ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet. 8, e1002920 (2012).","DOI":"10.1371\/journal.pgen.1002920"},{"key":"51676_CR37","doi-asserted-by":"crossref","unstructured":"Jim\u00e9nez-l\u00f3pez, D. & Guzm\u00e1n, P. Insights into the evolution and domain structure of ataxin-2 proteins across eukaryotes. BMC Res. Notes 7, 453 (2014).","DOI":"10.1186\/1756-0500-7-453"},{"key":"51676_CR38","doi-asserted-by":"crossref","unstructured":"Dansithong, W. et al. Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model. PLoS Genet. 11, e1005182 (2015).","DOI":"10.1371\/journal.pgen.1005182"},{"key":"51676_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10048-015-0441-5","volume":"16","author":"M Fittschen","year":"2015","unstructured":"Fittschen, M. et al. Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate. Neurogenetics 16, 181\u2013192 (2015).","journal-title":"Neurogenetics"},{"key":"51676_CR40","doi-asserted-by":"crossref","unstructured":"Meierhofer, D. et al. Ataxin-2 (Atxn2) -knock-out mice show branched chain amino acids and fatty acids pathway alterations*. Mol. Cell Proteomics 15, 1728\u20131739 (2016).","DOI":"10.1074\/mcp.M115.056770"},{"key":"51676_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00401-012-0985-5","volume":"124","author":"MP Hart","year":"2012","unstructured":"Hart, M. P., Brettschneider, J., Lee, V. M. Y., Trojanowski, J. Q. & Gitler, A. D. Distinct TDP-43 pathology in ALS patients with ataxin 2 intermediate-length polyQ expansions. Acta Neuropathol. 124, 221\u2013230 (2012).","journal-title":"Acta Neuropathol."},{"key":"51676_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.molmed.2013.09.001","volume":"20","author":"DMA van den Heuvel","year":"2014","unstructured":"van den Heuvel, D. M. A., Harschnitz, O., van den Berg, L. H. & Pasterkamp, R. J. Taking a risk: a therapeutic focus on ataxin-2 in amyotrophic lateral sclerosis? Trends Mol. Med. 20, 25\u201335 (2014).","journal-title":"Trends Mol. Med."},{"key":"51676_CR43","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tins.2017.06.004","volume":"40","author":"G Auburger","year":"2017","unstructured":"Auburger, G., Sen, N.-E., Meierhofer, D., Ba\u015fak, A.-N. & Gitler, A. D. Efficient prevention of neurodegenerative diseases by depletion of starvation response factor ataxin-2. Trends Neurosci. 40, 507\u2013516 (2017).","journal-title":"Trends Neurosci."},{"key":"51676_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 8, 861 (2017).","journal-title":"Nat. Commun."},{"key":"51676_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molmed.2020.09.013","volume":"27","author":"S Pasteuning-Vuhman","year":"2021","unstructured":"Pasteuning-Vuhman, S., de Jongh, R., Timmers, A. & Pasterkamp, R. J. Towards advanced iPSC-based drug development for neurodegenerative disease. Trends Mol. Med. 27, 263\u2013279 (2021).","journal-title":"Trends Mol. Med."},{"key":"51676_CR46","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.neuron.2024.04.025","volume":"112","author":"Q Cui","year":"2024","unstructured":"Cui, Q., Liu, Z. & Bai, G. Friend or foe: the role of stress granule in neurodegenerative disease. Neuron 112, 2464\u20132485 (2024).","journal-title":"Neuron"},{"key":"51676_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12099-4","volume":"10","author":"T Vandoorne","year":"2019","unstructured":"Vandoorne, T. et al. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat. Commun. 10, 4147 (2019).","journal-title":"Nat. Commun."},{"key":"51676_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2018.09.024","volume":"121","author":"D Gordon","year":"2019","unstructured":"Gordon, D. et al. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiol. Dis. 121, 148\u2013162 (2019).","journal-title":"Neurobiol. Dis."},{"key":"51676_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ana.24565","volume":"79","author":"RH Tan","year":"2016","unstructured":"Tan, R. H. et al. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions. Ann. Neurol. 79, 295\u2013305 (2016).","journal-title":"Ann. Neurol."},{"key":"51676_CR50","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1136\/jnnp-2021-326854","volume":"92","author":"P Bede","year":"2021","unstructured":"Bede, P. et al. Genotype-associated cerebellar profiles in ALS: focal cerebellar pathology and cerebro-cerebellar connectivity alterations. J. Neurol. Neurosurg. Psychiatry 92, 1197\u20131205 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"51676_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16772-5","volume":"12","author":"R Kabiljo","year":"2022","unstructured":"Kabiljo, R., Iacoangeli, A., Al-Chalabi, A. & Rosenzweig, I. Amyotrophic lateral sclerosis and cerebellum. Sci. Rep. 12, 12586 (2022).","journal-title":"Sci. Rep."},{"key":"51676_CR52","doi-asserted-by":"crossref","unstructured":"Scoles, D. R. et al. ALS-associated genes in SCA2 mouse spinal cord transcriptomes. Hum. Mol. Genet. 29, 1658\u20131672 (2020).","DOI":"10.1093\/hmg\/ddaa072"},{"key":"51676_CR53","doi-asserted-by":"publisher","first-page":"108822","DOI":"10.1016\/j.intimp.2022.108822","volume":"109","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Apelin\/APJ system in inflammation. Int. Immunopharmacol. 109, 108822 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"51676_CR54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.clim.2015.12.012","volume":"163","author":"KT Maleki","year":"2016","unstructured":"Maleki, K. T., Cornillet, M. & Bj\u00f6rkstr\u00f6m, N. K. Soluble SEMA4D\/CD100: a novel immunoregulator in infectious and inflammatory diseases. Clin. Immunol. 163, 52\u201359 (2016).","journal-title":"Clin. Immunol."},{"key":"51676_CR55","doi-asserted-by":"crossref","unstructured":"Tian, M. et al. Functions of regulators of G protein signaling 16 in immunity, inflammation, and other diseases. Front. Mol. Biosci. 9, 962321 (2022).","DOI":"10.3389\/fmolb.2022.962321"},{"key":"51676_CR56","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1038\/s41423-021-00721-9","volume":"18","author":"M Benkhoucha","year":"2021","unstructured":"Benkhoucha, M. et al. c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells. Cell. Mol. Immunol. 18, 2051\u20132053 (2021).","journal-title":"Cell. Mol. Immunol."},{"key":"51676_CR57","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1172\/JCI90607","volume":"127","author":"D Lall","year":"2017","unstructured":"Lall, D. & Baloh, R. H. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia. J. Clin. Invest. 127, 3250\u20133258 (2017).","journal-title":"J. Clin. Invest."},{"key":"51676_CR58","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke, B. E. & Patani, R. The microglial component of amyotrophic lateral sclerosis. Brain 143, 3526\u20133539 (2020).","journal-title":"Brain"},{"key":"51676_CR59","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","volume":"110","author":"RC Paolicelli","year":"2022","unstructured":"Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458\u20133483 (2022).","journal-title":"Neuron"},{"key":"51676_CR60","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"51676_CR61","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna, M. & Butovsky, O. Microglia function in the central nervous system during health and neurodegeneration. Annu. Rev. Immunol. 35, 441\u2013468 (2017).","journal-title":"Annu. Rev. Immunol."},{"key":"51676_CR62","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1128\/JVI.02613-15","volume":"90","author":"JE Vincenti","year":"2015","unstructured":"Vincenti, J. E. et al. Defining the microglia response during the time course of chronic neurodegeneration. J. Virol. 90, 3003\u20133017 (2015).","journal-title":"J. Virol."},{"key":"51676_CR63","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","volume":"7","author":"ME Lull","year":"2010","unstructured":"Lull, M. E. & Block, M. L. Microglial activation and chronic neurodegeneration. Neurotherapeutics 7, 354\u2013365 (2010).","journal-title":"Neurotherapeutics"},{"key":"51676_CR64","doi-asserted-by":"crossref","unstructured":"Lloyd, A. F. et al. Deep proteomic analysis of human microglia and model systems reveal fundamental biological differences of in vitro and ex vivo cells. bioRxiv https:\/\/www.biorxiv.org\/content\/10.1101\/2022.07.07.498804v1 (2022).","DOI":"10.1101\/2022.07.07.498804"},{"key":"51676_CR65","doi-asserted-by":"crossref","unstructured":"Ormel, P. R. et al. Microglia innately develop within cerebral organoids. Nat. Commun. 9, 4167 (2018).","DOI":"10.1038\/s41467-018-06684-2"},{"key":"51676_CR66","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581.e9 (2017).","journal-title":"Immunity"},{"key":"51676_CR67","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","volume":"59","author":"S Verma","year":"2022","unstructured":"Verma, S. et al. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol. Neurobiol. 59, 1502\u20131527 (2022).","journal-title":"Mol. Neurobiol."},{"key":"51676_CR68","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","volume":"19","author":"M Wong","year":"2010","unstructured":"Wong, M. & Martin, L. J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 19, 2284\u20132302 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bpa.12350","volume":"26","author":"J-P Loeffler","year":"2016","unstructured":"Loeffler, J.-P., Picchiarelli, G., Dupuis, L. & Gonzalez De Aguilar, J.-L. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 26, 227\u2013236 (2016).","journal-title":"Brain Pathol."},{"key":"51676_CR70","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neubiorev.2009.03.004","volume":"33","author":"J Prodoehl","year":"2009","unstructured":"Prodoehl, J., Corcos, D. M. & Vaillancourt, D. E. Basal ganglia mechanisms underlying precision grip force control. Neurosci. Biobehav. Rev. 33, 900 (2009).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"51676_CR71","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/79162","volume":"26","author":"DP Huynh","year":"2000","unstructured":"Huynh, D. P., Figueroa, K., Hoang, N. & Pulst, S.-M. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat. Genet. 26, 44\u201350 (2000).","journal-title":"Nat. Genet."},{"key":"51676_CR72","doi-asserted-by":"publisher","first-page":"E736","DOI":"10.1073\/pnas.1222809110","volume":"110","author":"ES Arnold","year":"2013","unstructured":"Arnold, E. S. et al. ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc. Natl Acad. Sci. 110, E736\u2013E745 (2013).","journal-title":"Proc. Natl Acad. Sci."},{"key":"51676_CR73","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1073\/pnas.1317317111","volume":"111","author":"JA Austin","year":"2014","unstructured":"Austin, J. A. et al. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life. Proc. Natl Acad. Sci. 111, 4309\u20134314 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"51676_CR74","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1083\/jcb.201302044","volume":"201","author":"YR Li","year":"2013","unstructured":"Li, Y. R., King, O. D., Shorter, J. & Gitler, A. D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 201, 361\u2013372 (2013).","journal-title":"J. Cell Biol."},{"key":"51676_CR75","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","volume":"79","author":"S-C Ling","year":"2013","unstructured":"Ling, S.-C., Polymenidou, M. & Cleveland, D. W. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416\u2013438 (2013).","journal-title":"Neuron"},{"key":"51676_CR76","doi-asserted-by":"crossref","unstructured":"Nonhoff, U. et al. Ataxin-2 interacts with the DEAD\/H-Box RNA helicase DDX6 and interferes with p-bodies and stress granules. Mol. Biol. Cell 18, 1385\u20131396 (2007).","DOI":"10.1091\/mbc.e06-12-1120"},{"key":"51676_CR77","doi-asserted-by":"publisher","first-page":"R173","DOI":"10.1093\/hmg\/ddg295","volume":"12","author":"A Michalik","year":"2003","unstructured":"Michalik, A. & Van Broeckhoven, C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum. Mol. Genet. 12, R173\u2013R186 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR78","doi-asserted-by":"publisher","first-page":"9148","DOI":"10.1523\/JNEUROSCI.0660-09.2009","volume":"29","author":"J Liu","year":"2009","unstructured":"Liu, J. et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J. Neurosci. 29, 9148\u20139162 (2009).","journal-title":"J. Neurosci."},{"key":"51676_CR79","doi-asserted-by":"crossref","unstructured":"Arsovi\u0107, A. et al. Mouse ataxin-2 expansion downregulates camkii and other calcium signaling factors, impairing granule\u2014purkinje neuron synaptic strength. Int. J. Mol. Sci. 21, 6673 (2020).","DOI":"10.3390\/ijms21186673"},{"key":"51676_CR80","doi-asserted-by":"publisher","first-page":"105289","DOI":"10.1016\/j.nbd.2021.105289","volume":"152","author":"J Canet-Pons","year":"2021","unstructured":"Canet-Pons, J. et al. Atxn2-CAG100-KnockIn mouse spinal cord shows progressive TDP43 pathology associated with cholesterol biosynthesis suppression. Neurobiol. Dis. 152, 105289 (2021).","journal-title":"Neurobiol. Dis."},{"key":"51676_CR81","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/hmg\/dds479","volume":"22","author":"MA Farg","year":"2013","unstructured":"Farg, M. A. et al. Ataxin-2 interacts with FUS and intermediate-length polyglutamine expansions enhance FUS-related pathology in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 717\u2013728 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"51676_CR82","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.15252\/embj.201593350","volume":"35","author":"C Sellier","year":"2016","unstructured":"Sellier, C. et al. Loss of C9 ORF 72 impairs autophagy and synergizes with polyQ Ataxin\u20102 to induce motor neuron dysfunction and cell death. EMBO J. 35, 1276\u20131297 (2016).","journal-title":"EMBO J."},{"key":"51676_CR83","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","volume":"133","author":"J Nijssen","year":"2017","unstructured":"Nijssen, J., Comley, L. H. & Hedlund, E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 133, 863\u2013885 (2017).","journal-title":"Acta Neuropathol."},{"key":"51676_CR84","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang, W. et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 22, 869\u2013878 (2016).","journal-title":"Nat. Med."},{"key":"51676_CR85","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1021\/acs.jproteome.6b00647","volume":"16","author":"G Seidel","year":"2017","unstructured":"Seidel, G. et al. Quantitative global proteomics of yeast PBP1 deletion mutants and their stress responses identifies glucose metabolism, mitochondrial, and stress granule changes. J. Proteome Res. 16, 504\u2013515 (2017).","journal-title":"J. Proteome Res."},{"key":"51676_CR86","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mito.2017.03.001","volume":"34","author":"N Cornelius","year":"2017","unstructured":"Cornelius, N. et al. Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters. Mitochondrion 34, 103\u2013114 (2017).","journal-title":"Mitochondrion"},{"key":"51676_CR87","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00401-018-1933-9","volume":"137","author":"ME Mccauley","year":"2019","unstructured":"Mccauley, M. E. & Baloh, R. H. Inflammation in ALS\/FTD pathogenesis. Acta Neuropathol. 137, 715\u2013730 (2019).","journal-title":"Acta Neuropathol."},{"key":"51676_CR88","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/glia.20919","volume":"58","author":"W Zhao","year":"2010","unstructured":"Zhao, W. et al. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58, 231\u2013243 (2010).","journal-title":"Glia"},{"key":"51676_CR89","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"51676_CR90","doi-asserted-by":"crossref","unstructured":"Bright, F., Chan, G., van Hummel, A., Ittner, L. M. & Ke, Y. D. TDP-43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia. Int. J. Mol. Sci. 22, 7781 (2022).","DOI":"10.3390\/ijms22157781"},{"key":"51676_CR91","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41593-018-0083-7","volume":"21","author":"KJ Spiller","year":"2018","unstructured":"Spiller, K. J. et al. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy. Nat. Neurosci. 21, 329\u2013340 (2018).","journal-title":"Nat. Neurosci."},{"key":"51676_CR92","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s40478-021-01239-x","volume":"9","author":"M Hunter","year":"2021","unstructured":"Hunter, M. et al. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery. Acta Neuropathol. Commun. 9, 140 (2021).","journal-title":"Acta Neuropathol. Commun."},{"key":"51676_CR93","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman, S., Izzy, S., Sen, P., Morsett, L. & El Khoury, J. Microglia in neurodegeneration. Nat. Neurosci. 21, 1359\u20131369 (2018).","journal-title":"Nat. Neurosci."},{"key":"51676_CR94","doi-asserted-by":"crossref","unstructured":"Trias, E. et al. Emergence of microglia bearing senescence markers during paralysis progression in a rat model of inherited ALS. Front. Aging Neurosci. 11, 42 (2019).","DOI":"10.3389\/fnagi.2019.00042"},{"key":"51676_CR95","doi-asserted-by":"publisher","first-page":"eaal3222","DOI":"10.1126\/science.aal3222","volume":"356","author":"D Gosselin","year":"2017","unstructured":"Gosselin, D. et al. An environment-dependent transcriptional network specifies human microglia identity. Science 356, eaal3222 (2017).","journal-title":"Science"},{"key":"51676_CR96","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.cell.2019.11.010","volume":"179","author":"L Geirsdottir","year":"2019","unstructured":"Geirsdottir, L. et al. Cross-species single-cell analysis reveals divergence of the primate microglia program. Cell 179, 1609\u20131622.e16 (2019).","journal-title":"Cell"},{"key":"51676_CR97","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/s41586-019-0924-x","volume":"566","author":"Masuda","year":"2019","unstructured":"Masuda et al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566, 388\u2013392 (2019).","journal-title":"Nature"},{"key":"51676_CR98","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41596-020-00447-4","volume":"16","author":"N Fattorelli","year":"2021","unstructured":"Fattorelli, N. et al. Stem-cell-derived human microglia transplanted into mouse brain to study human disease. Nat. Protoc. 16, 1013\u20131033 (2021).","journal-title":"Nat. Protoc."},{"key":"51676_CR99","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073\u20131081 (2018).","journal-title":"Cell"},{"key":"51676_CR100","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neubiorev.2018.01.003","volume":"87","author":"N Kafkafi","year":"2018","unstructured":"Kafkafi, N. et al. Reproducibility and replicability of rodent phenotyping in preclinical studies. Neurosci. Biobehav. Rev. 87, 218\u2013232 (2018).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"51676_CR101","doi-asserted-by":"crossref","unstructured":"Doetschman, T. Influence of genetic background on genetically engineered mouse phenotypes BT - gene knockout protocols: 2nd Edn. In: W. Wurst and R. K\u00fchn, eds. (Humana Press), pp. 423\u2013433 (2009).","DOI":"10.1007\/978-1-59745-471-1_23"},{"key":"51676_CR102","doi-asserted-by":"publisher","first-page":"16325","DOI":"10.1073\/pnas.1003459107","volume":"107","author":"X Shan","year":"2010","unstructured":"Shan, X., Chiang, P.-M., Price, D. L. & Wong, P. C. Altered distributions of Gemini of coiled bodies and mitochondria in motor neurons of TDP-43 transgenic mice. Proc. Natl Acad. Sci. 107, 16325\u201316330 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"51676_CR103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40478-015-0212-4","volume":"3","author":"JC Mitchell","year":"2015","unstructured":"Mitchell, J. C. et al. Wild type human TDP-43 potentiates ALS-linked mutant TDP-43 driven progressive motor and cortical neuron degeneration with pathological features of ALS. Acta Neuropathol. Commun. 3, 36 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"51676_CR104","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41593-018-0113-5","volume":"21","author":"MA White","year":"2018","unstructured":"White, M. A. et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 21, 552\u2013563 (2018).","journal-title":"Nat. Neurosci."},{"key":"51676_CR105","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/joa.13463","volume":"241","author":"A Alhindi","year":"2022","unstructured":"Alhindi, A., Boehm, I. & Chaytow, H. Small junction, big problems: neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS). J. Anat. 241, 1089\u20131107 (2022).","journal-title":"J. Anat."},{"key":"51676_CR106","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1101\/gr.476202","volume":"12","author":"S Gong","year":"2002","unstructured":"Gong, S., Yang, X. W., Li, C. & Heintz, N. Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication. Genome Res. 12, 1992\u20131998 (2002).","journal-title":"Genome Res."},{"key":"51676_CR107","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","volume":"26","author":"K Meyer","year":"2019","unstructured":"Meyer, K. et al. REST and neural gene network dysregulation in iPSC models of Alzheimer\u2019s disease. Cell Rep. 26, 1112\u20131127.e9 (2019).","journal-title":"Cell Rep."},{"key":"51676_CR108","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nm.4490","volume":"24","author":"Y Shi","year":"2018","unstructured":"Shi, Y. et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS\/FTD human induced motor neurons. Nat. Med. 24, 313\u2013325 (2018).","journal-title":"Nat. Med."},{"key":"51676_CR109","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/stem.2354","volume":"34","author":"M Naujock","year":"2016","unstructured":"Naujock, M. et al. 4-Aminopyridine induced activity rescues hypoexcitable motor neurons from amyotrophic lateral sclerosis patient-derived induced pluripotent stem cells. Stem Cells 34, 1563\u20131575 (2016).","journal-title":"Stem Cells"},{"key":"51676_CR110","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ana.24680","volume":"80","author":"Harschnitz","year":"2016","unstructured":"Harschnitz et al. Autoantibody pathogenicity in a multifocal motor neuropathy induced pluripotent stem cell\u2013derived model. Ann. Neurol. 80, 71\u201388 (2016).","journal-title":"Ann. Neurol."},{"key":"51676_CR111","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1523\/JNEUROSCI.0906-12.2013","volume":"33","author":"MW Amoroso","year":"2013","unstructured":"Amoroso, M. W. et al. Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J. Neurosci. 33, 574\u2013586 (2013).","journal-title":"J. Neurosci."},{"key":"51676_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7626","volume":"6","author":"ZW Du","year":"2015","unstructured":"Du, Z. W. et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat. Commun. 6, 1\u20139 (2015).","journal-title":"Nat. Commun."},{"key":"51676_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26347-y","volume":"8","author":"IdoCG Gon\u00e7alves","year":"2018","unstructured":"Gon\u00e7alves, IdoC. G. et al. Neuronal activity regulates DROSHA via autophagy in spinal muscular atrophy. Sci. Rep. 8, 7907 (2018).","journal-title":"Sci. Rep."},{"key":"51676_CR114","doi-asserted-by":"crossref","unstructured":"Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373\u2013379 (2013).","DOI":"10.1038\/nature12517"},{"key":"51676_CR115","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/nbt.2959","volume":"32","author":"PJP de Vree","year":"2014","unstructured":"de Vree, P. J. P. et al. Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping. Nat. Biotechnol. 32, 1019\u20131025 (2014).","journal-title":"Nat. Biotechnol."},{"key":"51676_CR116","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1016\/j.neurobiolaging.2014.03.025","volume":"35","author":"DDA Raj","year":"2014","unstructured":"Raj, D. D. A. et al. Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol. Aging 35, 2147\u20132160 (2014).","journal-title":"Neurobiol. Aging"},{"key":"51676_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-016-0938-8","volume":"17","author":"T Hashimshony","year":"2016","unstructured":"Hashimshony, T. et al. CEL-Seq2: sensitive highly-multiplexed single-cell RNA-Seq. Genome Biol. 17, 1\u20137 (2016).","journal-title":"Genome Biol."},{"key":"51676_CR118","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.cels.2016.09.002","volume":"3","author":"MJ Muraro","year":"2016","unstructured":"Muraro, M. J. et al. A single-cell transcriptome atlas of the human pancreas. Cell Syst. 3, 385\u2013394.e3 (2016).","journal-title":"Cell Syst."},{"key":"51676_CR119","doi-asserted-by":"publisher","first-page":"25.2.1","DOI":"10.1002\/0471140856.tx2502s60","volume":"60","author":"AS Divakaruni","year":"2014","unstructured":"Divakaruni, A. S., Rogers, G. W. & Murphy, A. N. Measuring mitochondrial function in permeabilized cells using the seahorse XF analyzer or a clark-type oxygen electrode. Curr. Protoc. Toxicol. 60, 25.2.1\u201325.2.16 (2014).","journal-title":"Curr. Protoc. Toxicol."},{"key":"51676_CR120","doi-asserted-by":"crossref","unstructured":"Zhang, L. & Trushina, E. Respirometry in neurons BT - techniques to investigate mitochondrial function in neurons. In: S. Strack and Y. M. Usachev, eds. (Springer New York), pp. 95\u2013113 (2017).","DOI":"10.1007\/978-1-4939-6890-9_5"},{"key":"51676_CR121","doi-asserted-by":"publisher","first-page":"160240","DOI":"10.1098\/rsob.160240","volume":"6","author":"RA Jones","year":"2016","unstructured":"Jones, R. A. et al. NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction. Open Biol. 6, 160240 (2016).","journal-title":"Open Biol."},{"key":"51676_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91094-6","volume":"11","author":"A Mejia Maza","year":"2021","unstructured":"Mejia Maza, A. et al. NMJ-analyser identifies subtle early changes in mouse models of neuromuscular disease. Sci. Rep. 11, 12251 (2021).","journal-title":"Sci. Rep."},{"key":"51676_CR123","doi-asserted-by":"crossref","unstructured":"Br\u00fcll, M., Geese, N., Celardo, I., Laumann, M. & Leist, M. Preparation of viable human neurites for neurobiological and neurodegeneration studies. Cells 13, 24 (2024).","DOI":"10.3390\/cells13030242"},{"key":"51676_CR124","doi-asserted-by":"crossref","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102, 15545\u201315550 (2005).","DOI":"10.1073\/pnas.0506580102"},{"key":"51676_CR125","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1101\/gr.133744.111","volume":"22","author":"S Anders","year":"2012","unstructured":"Anders, S., Reyes, A. & Huber, W. Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008\u20132017 (2012).","journal-title":"Genome Res."},{"key":"51676_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"51676_CR127","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature14966","volume":"525","author":"D Gr\u00fcn","year":"2015","unstructured":"Gr\u00fcn, D. et al. Single-cell messenger RNA sequencing reveals rare intestinal cell types. Nature 525, 251\u2013255 (2015).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51676-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51676-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:03:06Z","timestamp":1724932986000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51676-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51676"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51676-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"24 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7484"}}